BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8813099)

  • 1. Immediate or delayed therapy with 2-CdA for hairy cell leukemia in Jehova's Witness?
    Juliusson G
    Am J Hematol; 1996 Sep; 53(1):49. PubMed ID: 8813099
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
    Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hairy-cell leukemia: current views.
    Tallman MS; Peterson LC; Hakimian D; Gillis S; Polliack A
    Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypersensitivity reactions to multiple drugs during the course of hairy cell leukemia treated with 2-chlorodeoxyadenosine].
    Kokunai A; Azusawa H; Murota H; Ohhata C; Katayama I; Murata S; Tadokoro S
    Arerugi; 2006 Jun; 55(6):662-6. PubMed ID: 16883103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alpha interferon treatment in hairy cell leukemia].
    Hagberg H
    Nord Med; 1992; 107(3):74-5. PubMed ID: 1347920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.
    Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
    Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptococcus neoformans meningitis in a patient with hairy cell leukemia.
    Dinçol G; Kahraman R
    Am J Hematol; 2006 May; 81(5):387. PubMed ID: 16628737
    [No Abstract]   [Full Text] [Related]  

  • 8. Cryptococcal meningitis occurring at 19 months after cladribine therapy for hairy cell leukemia.
    Ikpeazu EV; Kaplon MK
    Eur J Haematol; 1998 Oct; 61(4):286-7. PubMed ID: 9820640
    [No Abstract]   [Full Text] [Related]  

  • 9. Hairy cell leukemia: treatment successes in the past 25 years.
    Golomb HM
    J Clin Oncol; 2008 Jun; 26(16):2607-9. PubMed ID: 18509168
    [No Abstract]   [Full Text] [Related]  

  • 10. Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin.
    Prescrire Int; 2006 Aug; 15(84):143-4. PubMed ID: 16989031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha interferon in the treatment of hairy cell leukemia.
    Tambone Reyes M; Gebbia V; Teresi M; Bonaccorso R; Colucci A; Quartararo L; Di Marco P; Citarrella P; Mansueto S
    J Chemother; 1989 Jul; 1(4 Suppl):1264-5. PubMed ID: 16312859
    [No Abstract]   [Full Text] [Related]  

  • 12. Ultrastructural changes of retinal ganglion cells in rabbits of New Zealand breed after experimental administration of 2-CDA (Cladribine).
    Kwietniewska M; Cybulska R; Kwietniewski P; Sekita-Krzak J; Czerny K
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):381-6. PubMed ID: 12898866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium-avium-intracellulare complex infection following 2-chlorodeoxyadenosine therapy for hairy cell leukaemia.
    Broady R; Roberts S; Hawkins T
    Leuk Lymphoma; 2000 Feb; 36(5-6):639-42. PubMed ID: 10784410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
    Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases.
    Palomera L; Domingo JM; Sola C; Azaceta G; Calvo MT; Gutierrez M
    Haematologica; 2002 Jan; 87(1):107-8. PubMed ID: 11801472
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hairy cell leukemia: Part II: therapy with cladribine].
    Barth J; Rummel MJ
    Med Monatsschr Pharm; 2009 Jul; 32(7):252-60. PubMed ID: 19731753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hairy cell leukaemia (HCL) with 2-chlorodeoxyadenosine (2-CdA): identification of parameters predictive of adverse effects.
    Legrand O; Vekhoff A; Marie JP; Zittoun R; Delmer A
    Br J Haematol; 1997 Oct; 99(1):165-7. PubMed ID: 9359518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological examination of the retinal ganglion layer in rabbits after experimental administration of the new immunosuppressive medicine--Cladribine.
    Kwietniewska M; Cybulska R; Kwietniewski P; Sekita-Krzak J; Czerny K
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):376-80. PubMed ID: 12898865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intermittent interferon alfa in the treatment of hairy cell leukemia].
    Gómez-Almaguer D; Jaime-Pérez JC; Herrera-Garza JL; González-Llano O
    Rev Invest Clin; 1998; 50(4):331-4. PubMed ID: 9830322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired interferon alpha response in hairy cell leukemia is corrected by therapy with 2-chloro-2'-deoxyadenosine: implications for susceptibility to opportunistic infections.
    Siegal FP; Shodell M; Shah K; Drake D; Hoffman M; Sawitsky A; Janson D; Fitzgerald-Bocarsly P; Rai KR
    Leukemia; 1994 Sep; 8(9):1474-9. PubMed ID: 7916389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.